Cynthia Helsabeck

695 total citations
15 papers, 553 citations indexed

About

Cynthia Helsabeck is a scholar working on Oncology, Epidemiology and Hepatology. According to data from OpenAlex, Cynthia Helsabeck has authored 15 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Epidemiology and 4 papers in Hepatology. Recurrent topics in Cynthia Helsabeck's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Cynthia Helsabeck is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Cynthia Helsabeck collaborates with scholars based in United States and India. Cynthia Helsabeck's co-authors include H. Richard Alexander, James F. Pingpank, Steven K. Libutti, Seth M. Steinberg, Tatiana Beresneva, Linda S. Callans, Brian J. Czerniecki, Francis R. Spitz, Douglas L. Fraker and Isabelle Bedrosian and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and American Journal of Ophthalmology.

In The Last Decade

Cynthia Helsabeck

15 papers receiving 538 citations

Peers

Countries citing papers authored by Cynthia Helsabeck

Since Specialization

Citations

This map shows the geographic impact of Cynthia Helsabeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cynthia Helsabeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cynthia Helsabeck more than expected).

Fields of papers citing papers by Cynthia Helsabeck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cynthia Helsabeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cynthia Helsabeck. The network helps show where Cynthia Helsabeck may publish in the future.

Co-authorship network of co-authors of Cynthia Helsabeck

This figure shows the co-authorship network connecting the top 25 collaborators of Cynthia Helsabeck. A scholar is included among the top collaborators of Cynthia Helsabeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cynthia Helsabeck. Cynthia Helsabeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors 2014 ·Oncotarget ·Gideon M. Blumenthal, Joell J. Gills, Marc Ballas, Wendy B. Bernstein, Takefumi Komiya, (unknown), Betsy Morrow, (unknown), Guinevere Chun, Cynthia Helsabeck, Seth M. Steinberg, Jaclyn LoPiccolo, Shigeru Kawabata, Erin R. Gardner, William D. Figg, Phillip A. Dennis	30
2	A phase I/II trial of pemetrexed and sirolimus in advanced NSCLC. 2010 ·Journal of Clinical Oncology ·Gideon M. Blumenthal, Marc Ballas, Michael E. Ernst, (unknown), Harlan D. Root, Cynthia Helsabeck, Guinevere Chun, William D. Figg, Giuseppe Giaccone, Philip A. Dennis	5
3	Analysis of Factors Associated with Outcome in Patients Undergoing Isolated Hepatic Perfusion for Unresectable Liver Metastases from Colorectal Center 2009 ·Annals of Surgical Oncology ·H. Richard Alexander, David L. Bartlett, Steven K. Libutti, James F. Pingpank, Douglas L. Fraker, Richard E. Royal, Seth M. Steinberg, Cynthia Helsabeck, Tatiana Beresneva	28
4	A phase I study of nelfinavir, an FDA approved HIV protease inhibitor, in adults with refractory solid tumors 2009 ·Journal of Clinical Oncology ·Phillip A. Dennis, Gideon M. Blumenthal, Marc Ballas, Erin R. Gardner, Shigeru Kawabata, Jaclyn LoPiccolo, Cynthia Helsabeck, (unknown), William D. Figg, Michael E. Ernst	1
5	Isolated Hepatic Perfusion for the Treatment of Patients With Colorectal Cancer Liver Metastases After Irinotecan-Based Therapy 2005 ·Annals of Surgical Oncology ·H. Richard Alexander, Steven K. Libutti, James F. Pingpank, David L. Bartlett, Cynthia Helsabeck, Tatiana Beresneva	36
6	Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms 2004 ·Surgery ·Amelia Grover, Steven K. Libutti, James F. Pingpank, Cynthia Helsabeck, Tatiana Beresnev, H. Richard Alexander	25
7	Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion 2004 ·Journal of Gastrointestinal Surgery ·Elizabeth Feldman, Peter Wu, Tatiana Beresneva, Cynthia Helsabeck, (unknown), David L. Bartlett, Steven K. Libutti, James F. Pingpank, H. Richard Alexander	26
8	Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver 2004 ·American Journal of Ophthalmology ·H. Richard Alexander, Steven K. Libutti, James F. Pingpank, Seth M. Steinberg, (unknown), Cynthia Helsabeck, (unknown)	70
9	Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver. 2003 ·PubMed ·H. Richard Alexander, Steven K. Libutti, James F. Pingpank, Seth M. Steinberg, David L. Bartlett, Cynthia Helsabeck, Tatiana Beresneva	91
10	Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy 2002 ·Cancer ·H. Richard Alexander, Steven K. Libutti, David L. Bartlett, James F. Pingpank, Karen Kranda, Cynthia Helsabeck, Tatiana Beresnev	23
11	99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma. 1999 ·PubMed ·Isabelle Bedrosian, Alice M. Scheff, Rosemarie Mick, Linda S. Callans, Louis P. Bucky, Francis R. Spitz, Cynthia Helsabeck, David E. Elder, Abass Alavi, (unknown), Brian J. Czerniecki	34
12	Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma 1999 ·Cancer ·Brian J. Czerniecki, Alice M. Scheff, Linda S. Callans, Francis R. Spitz, Isabelle Bedrosian, Emily F. Conant, Susan G. Orel, Jesse A. Berlin, Cynthia Helsabeck, Douglas L. Fraker, Carol Reynolds	155
13	Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma 1999 ·Cancer ·Brian J. Czerniecki, Alice M. Scheff, Linda S. Callans, Francis R. Spitz, Isabelle Bedrosian, Emily F. Conant, Susan G. Orel, (unknown), Cynthia Helsabeck, Douglas L. Fraker, Carol Reynolds	16
14	The effects of heparin flush on patency of the Groshong catheter: a pilot study. 1996 ·PubMed ·Donna Jo Mayo, M K Horne, (unknown), (unknown), Cynthia Helsabeck	5
15	Intraluminal Clots in Groshong Catheters 1995 ·Donna Jo Mayo, Cynthia Helsabeck, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact